The Senate hearing into rare cancers hears patients are having to make do with very little indeed in the way of support and resources.
The Senate hearing into rare cancers hears patients are having to make do with very little indeed in the way of support and resources.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.